Technical Analysis for SEEL - Seelos Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Fell Below 20 DMA | Bearish | -7.99% | |
Wide Bands | Range Expansion | -7.99% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 16 hours ago |
Down 5% | about 16 hours ago |
Down 3% | about 16 hours ago |
Fell Below Previous Day's Low | about 16 hours ago |
Down 2 % | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/01/2024
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disorders Movement Disorders Orphan Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disorders Movement Disorders Orphan Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 49.8 |
52 Week Low | 0.7071 |
Average Volume | 380,787 |
200-Day Moving Average | 15.38 |
50-Day Moving Average | 1.09 |
20-Day Moving Average | 1.06 |
10-Day Moving Average | 1.09 |
Average True Range | 0.12 |
RSI (14) | 40.48 |
ADX | 18.18 |
+DI | 18.67 |
-DI | 26.79 |
Chandelier Exit (Long, 3 ATRs) | 1.00 |
Chandelier Exit (Short, 3 ATRs) | 1.12 |
Upper Bollinger Bands | 1.34 |
Lower Bollinger Band | 0.77 |
Percent B (%b) | 0.25 |
BandWidth | 53.71 |
MACD Line | -0.01 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.008 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.07 | ||||
Resistance 3 (R3) | 1.08 | 1.05 | 1.04 | ||
Resistance 2 (R2) | 1.05 | 1.01 | 1.04 | 1.03 | |
Resistance 1 (R1) | 0.98 | 0.98 | 0.96 | 0.97 | 1.03 |
Pivot Point | 0.95 | 0.95 | 0.94 | 0.94 | 0.95 |
Support 1 (S1) | 0.88 | 0.91 | 0.86 | 0.87 | 0.81 |
Support 2 (S2) | 0.85 | 0.88 | 0.84 | 0.80 | |
Support 3 (S3) | 0.78 | 0.85 | 0.79 | ||
Support 4 (S4) | 0.77 |